EHTH vs. MMC, AON, AJG, BRO, SLQT, WDH, TWFG, GOCO, RDZN, and ZBAO
Should you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), SelectQuote (SLQT), Waterdrop (WDH), TWFG (TWFG), GoHealth (GOCO), Roadzen (RDZN), and Zhibao Technology (ZBAO). These companies are all part of the "insurance agents, brokers, & service" industry.
eHealth vs.
eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MMC) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.
In the previous week, Marsh & McLennan Companies had 21 more articles in the media than eHealth. MarketBeat recorded 24 mentions for Marsh & McLennan Companies and 3 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.17 beat eHealth's score of 0.91 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.
eHealth has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Comparatively, Marsh & McLennan Companies has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.
79.5% of eHealth shares are owned by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are owned by institutional investors. 4.1% of eHealth shares are owned by insiders. Comparatively, 0.3% of Marsh & McLennan Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Marsh & McLennan Companies received 22 more outperform votes than eHealth when rated by MarketBeat users. However, 61.76% of users gave eHealth an outperform vote while only 61.66% of users gave Marsh & McLennan Companies an outperform vote.
eHealth presently has a consensus price target of $6.38, suggesting a potential downside of 36.57%. Marsh & McLennan Companies has a consensus price target of $228.60, suggesting a potential upside of 6.21%. Given Marsh & McLennan Companies' higher probable upside, analysts clearly believe Marsh & McLennan Companies is more favorable than eHealth.
Marsh & McLennan Companies has a net margin of 16.82% compared to eHealth's net margin of -7.58%. Marsh & McLennan Companies' return on equity of 32.65% beat eHealth's return on equity.
Summary
Marsh & McLennan Companies beats eHealth on 15 of the 18 factors compared between the two stocks.
Get eHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:EHTH) was last updated on 1/19/2025 by MarketBeat.com Staff
Free EHTH Stock Alerts